Quarterly ResultMay 15, 2026, 09:32 AM
Advanced Biomed 9-Month Net Income $5.98M on Divestment; Q3 Loss
AI Summary
Advanced Biomed Inc. reported a net income of $5.98 million for the nine months ended March 31, 2026, primarily driven by a $7.35 million gain from the divestment of its Hong Kong subsidiary. However, the company posted a net loss of $488,942 for the three-month period. Despite the nine-month profit, the company continues to face substantial doubt about its ability to continue as a going concern due to ongoing operating cash outflows.
Key Highlights
- Net income for the nine months ended March 31, 2026, was $5.98 million, compared to a loss of $2.56 million in the prior year.
- Net loss for the three months ended March 31, 2026, was $488,942, an improvement from a $1.38 million loss year-over-year.
- The company recorded a $7.35 million gain from the disposal of Advanced Biomed (HK) Limited.
- Total basic and diluted EPS for the nine-month period was $5.21, up from $(2.54) in the prior year.
- Total assets decreased to $10.65 million as of March 31, 2026, from $13.72 million as of June 30, 2025.
- Total liabilities significantly decreased to $1.44 million from $10.24 million over the same period.
- Net cash used in operating activities was $1.36 million for the nine months ended March 31, 2026.
- Completed a 1-for-20 reverse stock split on February 20, 2026, and a private placement raising $248,000.
Price Impact
More from ADVB